4.2 Article

Targeted Next Generation Sequencing Identifies Novel Mutations in RP1 as a Relatively Common Cause of Autosomal Recessive Rod-Cone Dystrophy

期刊

BIOMED RESEARCH INTERNATIONAL
卷 2015, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2015/485624

关键词

-

资金

  1. Foundation Voir et Entendre
  2. Prix Dalloz for la recherche en ophtalmologie
  3. Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO]
  4. FFB center [C-GE-0912-0601-INSERM02]
  5. Prix de la Fondation de l'OEil
  6. Ville de Paris
  7. Region Ile de France
  8. French State program Investissements d'Avenir [LIFESENSES: ANR-10-LABX-65]

向作者/读者索取更多资源

We report ophthalmic and genetic findings in families with autosomal recessive rod-cone dystrophy (arRCD) and RP1 mutations. Detailed ophthalmic examination was performed in 242 sporadic and arRCD subjects. Genomic DNA was investigated using our customized next generation sequencing panel targeting up to 123 genes implicated in inherited retinal disorders. Stringent filtering coupled with Sanger sequencing and followed by cosegregation analysis was performed to confirm biallelism and the implication of the most likely disease causing variants. Sequencing identified 9 RP1 mutations in 7 index cases. Eight of the mutations were novel, and all cosegregated with severe arRCD phenotype, found associated with additional macular changes. Among the identified mutations, 4 belong to a region, previously associated with arRCD, and 5 others in a region previously associated with adRCD. Our prevalence studies showed that RP1 mutations account for up to 2.5% of arRCD. These results point out for the necessity of sequencing RP1 when genetically investigating sporadic and arRCD. It further highlights the interest of unbiased sequencing technique, which allows investigating the implication of the same gene in different modes of inheritance. Finally, it reports that different regions of RP1 can also lead to arRCD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据